ENTRY       D08524                      Drug
NAME        Sorafenib (USAN/INN)
FORMULA     C21H16ClF3N4O3
EXACT_MASS  464.0863
MOL_WEIGHT  464.825
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
            Cyp substrate
             DG01633  CYP3A substrate
REMARK      ATC code: L01XE05
            Chemical group: DG00713
ACTIVITY    Antineoplastic, Tyrosine kinase inhibitor
COMMENT     Treatment of hepatocellular carcinoma, renal cell carcinoma
TARGET      RAF1 [HSA:5894] [KO:K04366];
            BRAF [HSA:673] [KO:K04365];
            FLT3 (CD135) [HSA:2322] [KO:K05092];
            PDGFRB [HSA:5159] [KO:K05089];
            VEGFR2 (KDR) [HSA:3791] [KO:K05098];
            VEGFR3 (FLT4) [HSA:2324] [KO:K05097];
            KIT (CD117) [HSA:3815] [KO:K05091];
            RET [HSA:5979] [KO:K05126]
  PATHWAY   hsa04010(5159+673)  MAPK signaling pathway
            hsa04012(673)  ErbB signaling pathway
            hsa04020(5159)  Calcium signaling pathway
            hsa04060(2322+2324+3791+3815+5159)  Cytokine-cytokine receptor interaction
            hsa04062(673)  Chemokine signaling pathway
            hsa04150(673)  mTOR signaling pathway
            hsa04370(3791)  VEGF signaling pathway
            hsa04650(673)  Natural killer cell mediated cytotoxicity
            hsa05200(2322+3815+5159+673)  Pathways in cancer
            hsa05211(673)  Renal cell carcinoma
METABOLISM  Enzyme: CYP3A4 [HSA:1576], UGT1A1 [HSA:54658], UGT1A9 [HSA:54600], CYP2B6 [HSA:1555], CYP2C9 [HSA:1559], CYP2C8 [HSA:1558]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinases inhibitors
OTHER_MAP   map04216  Ferroptosis
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XE Protein kinase inhibitors
                 L01XE05 Sorafenib
                  D08524  Sorafenib (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cytokine receptors
              Receptor tyrosine kinase
               RTK class III (PDGF receptor family)
                PDGFRB tyrosine kinase
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
                c-KIT tyrosine kinase
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
                Fms-related tyrosine kinase 3
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
               RTK class V (VEGF receptor family)
                VEGFR2 tyrosine kinase
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
                VEGFR3 tyrosine kinase
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
               RTK class XIV (RET receptor family)
                RET
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
             Protein kinases
              Serine/threonine protein kinases: TKL group
               RAF family
                BRAF
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
                proto-oncogene serine/threonine-protein kinase
                 Sorafenib
                  D08524  Sorafenib (USAN/INN)
            Cytochrome P450 interactions [BR:br08309]
             CYP substrates
              CYP2B6
               Sorafenib
                D08524  Sorafenib (USAN/INN)
              CYP2C8
               Sorafenib
                D08524  Sorafenib (USAN/INN)
              CYP2C9
               Sorafenib
                D08524  Sorafenib (USAN/INN)
DBLINKS     CAS: 284461-73-0
            PubChem: 96025209
            ChEBI: 50924
            ChEMBL: CHEMBL1336
            DrugBank: DB00398
            PDB-CCD: BAX
            LigandBox: D08524
            NIKKAJI: J1.961.269D
ATOM        32
            1   C8x C    30.1700  -18.6200
            2   C8y C    30.1700  -20.0200
            3   C8x C    31.3600  -20.7200
            4   C8x C    32.6200  -20.0200
            5   C8y C    32.6200  -18.6200
            6   C8y C    31.3600  -17.9200
            7   X   Cl   33.8100  -17.9200
            8   C1d C    31.3600  -16.5200
            9   X   F    31.3600  -15.1200
            10  N1b N    28.9800  -20.7200
            11  C5a C    27.7200  -20.0200
            12  N1b N    26.5300  -20.7200
            13  O5a O    27.7200  -18.6200
            14  C8y C    25.3400  -20.0200
            15  C8x C    25.3400  -18.6200
            16  C8x C    24.1500  -17.9200
            17  C8y C    22.9600  -18.6200
            18  C8x C    22.9600  -20.0200
            19  C8x C    24.1500  -20.7200
            20  O2a O    21.7000  -17.9200
            21  C8y C    20.5100  -18.6200
            22  C8x C    19.3200  -17.9200
            23  C8y C    18.1300  -18.6200
            24  N5x N    18.1300  -20.0200
            25  C8x C    19.3200  -20.7200
            26  C8x C    20.5100  -20.0200
            27  C5a C    16.8700  -17.9200
            28  N1b N    15.6800  -18.6200
            29  O5a O    16.8700  -16.5200
            30  C1a C    14.4900  -17.9200
            31  X   F    29.9600  -16.5200
            32  X   F    32.7600  -16.5200
BOND        34
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     6   8 1
            9     8   9 1
            10    2  10 1
            11   10  11 1
            12   11  12 1
            13   11  13 2
            14   12  14 1
            15   14  15 2
            16   15  16 1
            17   16  17 2
            18   17  18 1
            19   18  19 2
            20   14  19 1
            21   17  20 1
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 2
            26   24  25 1
            27   25  26 2
            28   21  26 1
            29   23  27 1
            30   27  28 1
            31   27  29 2
            32   28  30 1
            33    8  31 1
            34    8  32 1
///
